Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2017; 27(03): 318-323
DOI: 10.4103/ijri.IJRI_30_17
Musculoskeletal Radiology

CT-guided radiofrequency ablation in osteoid osteoma: Result from a tertiary cancer centre in India

Suyash S Kulkarni
Interventional Radiology Unit, Department of Radio-Diagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Nitin S Shetty
Interventional Radiology Unit, Department of Radio-Diagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Ashwin M Polnaya
Interventional Radiology Unit, Department of Radio-Diagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Amit Janu
Interventional Radiology Unit, Department of Radio-Diagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Suresh Kumar
Interventional Radiology Unit, Department of Radio-Diagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Ajay Puri
Department of Surgical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Ashish Gulia
Department of Surgical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Venkatesh Rangarajan
Department of Nuclear Medicine, Tata Memorial Centre, Mumbai, Maharashtra, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Aims: The aim of this study is to evaluate the clinical efficacy of computed tomography (CT)-guided radiofrequency (RF) ablation as a minimally invasive therapy for osteoid osteoma. Materials and Methods: This is a retrospective analysis of prospectively maintained data of 43 symptomatic osteoid osteoma patients who were treated by radiofrequency ablation (RFA). Forty out of 43 patients were naive cases and underwent primary treatment for osteoid osteoma with RFA, whereas 3 patients included in the study underwent RFA for local recurrence after having undergone surgical treatment. Diagnosis was based on clinical and characteristic imaging findings, and biopsy was done for cases with atypical presentation. Pre and post procedure Visual Analog Score (VAS) was documented in all cases. Monopolar RFA system was used in all patients, and the electrode was placed within the lesion nidus under CT guidance coaxially through 11G introducer needle. Ablation was performed at 90° C for 5 min. Results: Technical success rate of intranidal placement of electrode was 100%. The primary clinical success in our study was 97.7% (42 of 43), and the secondary clinical success was 100%.Pre and postprocedure VAS score in our study group was 7.8 and 0.4, respectively. Mean follow-up period in our study was 48 months (Range: 4–129 months).One patient had recurrence of pain 4 years after treatment and was treated successfully by a second session. Minor complications were seen in 3 patients with two cases of RF pad burns and one case of skin burn at the treatment site, and these were managed conservatively. No patients developed temporary/permanent neurological deficits, and no procedure-related mortality was seen in our study. Conclusion: CT-guided percutaneous RFA is a simple, safe, minimally invasive, and highly effective treatment option for osteoid osteoma with good long-term pain control and potentially low disease recurrence.

Keywords

Bone ablation - bone RFA - osteoid osteoma - PET-CT - radio frequency ablation


Publication History

Article published online:
27 July 2021

© 2017. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Motamedi D, Learch TJ, Ishimitsu DN, Motamedi K, Katz MD, Brien EW,et al. Thermal Ablation of Osteoid Osteoma: Overview and Step-by-Step Guide. Radiographics 2009;29:2127:41.
  • 2 Unni KK, Dahlin DC. Osteoid osteoma. In: Dahlin's bone tumors. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1996. p. 121-30.
  • 3 Cantwell CP, O'Byrne J, Eustace S. Radiofrequency ablation of osteoid osteoma with cooled probes and impedance-control energy delivery. AJR Am J Roentgenol 2006;186:244-8.
  • 4 Kransdorf MJ, Stull MA, Gilkey FW, Moser RP. Osteoid osteoma. Radiographics 1991;11:671-96.
  • 5 Kneisl JS, Simon MA. Medical management compared with operative treatment for osteoid-osteoma. J Bone Joint Surg Am1992;74:179-85.
  • 6 Liu PT, Kujak JL, Roberts CC, de Chadarevian JP. The vascular groove sign: Anew CT finding associated with osteoid osteomas. AJR Am J Roentgenol 2011;196:168-73.
  • 7 DP Barei, G Moreau, MT Scarborough, MD Neel. Percutaneous radiofrequency ablation of osteoid osteoma. Clin Orthop Relat Res 2000;:115-24.
  • 8 Rosenthal DI, Alexander A, Rosenberg AE, Springfield DS. Ablation of osteoid osteomas with a percutaneously placed electrode: Anew procedure. Radiology1992;183:29-33.
  • 9 Yip PS, Lam YL, Chan MK, Shu JS, Lai KC, So YC. Computed tomography-guided percutaneous radiofrequency ablation of osteoid osteoma: Local experience. Hong Kong Med J 2006;12:305-9.
  • 10 Efstathopoulos N, Sapkas G, Xypnitos FN, Lazarettos I, Korres D, Nikolaou VS. Recurrent intra-articular osteoid osteoma of the hip after radiofrequency ablation: Acase report and review of the literature. Cases J 2009;2:6439.
  • 11 Spouge AR, Thain LM. Osteoid osteoma: MR imaging revisited. Clin Imaging 2000;24:19-27.
  • 12 Zampa V, Bargellini I, Ortori S, Faggioni L, Cioni R, Bartolozzi C. Osteoid osteoma in atypical locations: The added value of dynamic gadolinium-enhanced MR imaging. Eur J Radiol 2009;71:527-35.
  • 13 Purandare NC, Rangarajan V, Shah SA, Sharma AR, Kulkarni SS, Kulkarni AV,et al. Therapeutic Response to Radiofrequency Ablation of Neoplastic Lesions: FDG PET/CT Findings, Radio Graphics 2011;31:201-13.
  • 14 Imperiale A, Moser T, Ben-Sellem D, Mertz L, Gangi A, Constantinesco A. Osteoblastoma and osteoid osteoma: Morphological characterization by MRI and dynamic F-18 FDG PET/CT before and after radiofrequency ablation. Clin Nucl Med 2009;34:184-8.
  • 15 Libordo G, Ghelman H. Osteoid osteoma. Medscape May 2015.
  • 16 Vogl TJ, Helmberger TK, Mack MG. Percutaneous Tumor Ablation in Medical Radiology. Springer Verlag; 2007. ISBN: 3540225188.
  • 17 Healey JH, Ghelman B. Osteoid osteoma and osteoblastoma. Current concepts and recent advances. Clinic Orthop Relat Res 1986;204:76-85.
  • 18 Parlier-Cuau C, Champsaur P, Nizard R, Hamze B, Laredo JD. Percutaneous removal of osteoid osteoma. Radiol Clin North Am 1998;36:559-66.
  • 19 Adam G, Keulers P, Vorwerk D, Heller KD, Füzesi L, Günther RW. The percutaneous CT-guided treatment of osteoid osteomas: Acombined procedure with a biopsy drill and subsequent ethanol injection. Fortschr Rontgenstr 1995;162:232-5.
  • 20 Gangi A, Dietemann JL, Clavert JM, Dodelin A, Mortazavi R, Durckel J, et al. Treatment of osteoid osteoma using laser photocoagulation. Apropos of 28 cases. Rev Chir Orthop Reparatrice Appar Mot 1998;84:676-84.
  • 21 Barei DP, Moreau G, Scarborough MT, Neel MD. Percutaneous radiofrequency ablation of osteoid osteoma. Clin Orthop 2000;373:115-24.
  • 22 Rosenthal DI, Springfield DS, Gebhardt MC, Rosenberg AE, Mankin HJ. Osteoid osteoma: Percutaneous radio-frequency ablation. Radiology 1995;197:451-4.
  • 23 Martel J, Bueno A, Ortiz E. Percutaneous radiofrequency treatment of osteoid osteoma using cool-tip electrodes. Eur J Radiol 2005;56:403-8.
  • 24 Lindner NJ, Ozaki T, Roedl R, Gosheger G, Winkelmann W, Wörtler K. Percutaneous radiofrequency ablation in osteoid osteoma. J Bone Joint Surg Br 2001;83:391-6.
  • 25 Jhankaria B, Burute N. Percutaneous radiofrequency ablation for osteoid osteoma: How we do it. Indian J Radiol Imaging 2009;19:36-42.
  • 26 Rehnitz C, Sprengel SD, Lehner B, Ludwig K, Omlor G, Merle C, et al. CT guided Radiofrequency ablation of osteoid osteoma: Correlation of clinical outcome and imaging features. Diagn Interv Radiol 2013;19:330-9.